I

Ipsen Global

Global biopharma focused on specialty care

Medical Affairs Director, Rare Diseases

Biology & BiotechConfirmed live in the last 24 hours
Full-timeParis, FranceNo salary listedIn-person

About the Job

Requirements

  • A medical degree, pharmacy degree, or scientific doctorate is required.
  • Substantial Medical Affairs experience in the pharmaceutical industry is required, ideally in rare diseases, specialty diseases, or therapeutically complex areas.
  • Demonstrated ability to define an ambitious strategic vision and ensure its operational implementation is required.
  • Ability to lead, unite, develop, and support teams toward shared objectives is required.
  • Scientific credibility and the ability to influence and interact effectively with healthcare experts, external partners, and senior stakeholders in a matrix organization are required.
  • Fluent French and English are required.

Responsibilities

  • Define and implement the medical and medical-marketing strategy in France for the rare-disease portfolio.
  • Develop and lead a strong network of experts and key opinion leaders.
  • Provide high-level scientific expertise to healthcare professionals and internal teams.
  • Lead local medical activities, including congresses, expert committees, scientific projects, publications, and clinical studies.
  • Collaborate closely with Market Access, Regulatory, Commercial, and Global Medical Affairs teams.
  • Manage and develop the Medical Affairs team.
  • Ensure activities comply with pharmaceutical-sector regulatory and ethical requirements.

Desired Qualifications

  • Experience in rare diseases, specialty diseases, or therapeutically complex areas is preferred.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs